Further transfection experiments with miRNA mimics indicated that miR-222 mimics could regulate drug resistance by targeting PTEN, with miR-222-rich EVs altering PTEN expression in drug-sensitive breast cancer cells[7]. Here, PTEN is linked to breast cancer.